Afgelopen week was er ESMO 2022. Hier een aantal aanbevolen abstracten over borstkanker  door Sara M. Tolaney, MD, MPH

Er zijn nog twee andere artsen die abstracten voor borstkanker aanbevelen, zoals Lee S. Schwartzberg MD, FACP en Benjamin O. Anderson MD, FACS.  De aanbevolen abstracten staan onder elkaar in dit artikel. Als u naar ESMO 2022 gaat kunt u via de nummers van de abstracten deze vinden.

Te beginnen met die van Sara M. Tolaney, MD, MPH 

Saturday, September 10, 2022
10:15–11:45 CEST; Proffered Paper Session
Breast Cancer, Early Stage

133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial. VC Tjan-Heijnen

134O Dose-dense adjuvant chemotherapy in early-stage breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella (GIM). L Del Mastro

Sunday, September 11, 2022
8:30–10:00 CEST; Proffered Paper Session
Supportive and Palliative Care

217O Patient-reported outcomes (PROs) from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low metastatic breast cancer (MBC). NT Ueno

1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxane-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial. L Michel

1553O Health-related quality of life (HRQoL) in the phase III TROPiCS-02 trial of sacituzumab govitecan (SG) vs chemotherapy in HR+/HER2- metastatic breast cancer (MBC). A Bardia

Aanbevolen abstracten door Benjamin O. Anderson MD, FACS  

Saturday, September 10, 2022
ePosters; Breast Cancer Early Stage

154P Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group. S Park

177P Health related quality of life in older breast cancer survivors. SH Giordano

179P Does undertreatment of elderly patients with early breast cancer impact outcome? JM Vasconcellos

180P Impact of Out-Of-Pocket (OOP) cost on breast cancer (BC) treatment persistence in the US: A systematic literature review (SLR). S Attri

183P Rates of risk-reduction mastectomy among women with inherited breast cancer. S Reid

199P Breast cancer overdiagnosis in England, 1995-2019. P Autier

Saturday, September 10, 2022
ePosters; Palliative Care

1267P Whether hospice-based palliative care is cost-effective in resource-limited settings of the Republic of Kazakhstan. I Salikhanov

Saturday, September 10, 2022
ePosters; Psycho-Oncology

1429P Impact of previous health-related events on coping with cancer. M Homa

1431P Improving psycho-oncologic attention by adding first psychological evaluation to a screening for psychosocial distress tool in recently diagnosed cancer patients. G Simó 

Sunday, September 11, 2022
10:15–11:45 CEST; Special Symposium
New Classification and Staging of Breast Cancer

Monday, September 12, 2022
E Posters Policy and Preventive Strategies

1326P Oncology under attack by predatory journals: A global survey. K El Bairi

1356P Socioeconomic vulnerabilities (SEV) and cancer-related mortality in United States (US): A cross-sectional analysis. SAA Naqv

Plaats een reactie ...

Reageer op "ESMO 2022: Aanbevolen abstracten gerelateerd aan borstkanker door vooraanstaande oncologen gepresenteerd op ESMO 2022"

Gerelateerde artikelen

Gerelateerde artikelen

ESMO 2022: Aanbevolen abstracten >> ESMO 2023: aanbevolen abstracten >>